| Literature DB >> 25601931 |
Keiko Yodoi1, Tomoya Yamashita2, Naoto Sasaki2, Kazuyuki Kasahara1, Takuo Emoto1, Takuya Matsumoto1, Tomoyuki Kita1, Yoshihiro Sasaki1, Taiji Mizoguchi1, Tim Sparwasser1, Ken-ichi Hirata1.
Abstract
Although regulatory T cells (Tregs) have been shown to play a protective role in abdominal aortic aneurysm (AAA) formation, it remains unclear whether expansion of endogenous Foxp3(+) Tregs prevents AAA. In the current study, we determined the effects of endogenous Foxp3(+) Treg expansion or depletion in an experimental model of AAA. We continuously infused 12-week-old apolipoprotein E-deficient mice fed a high-cholesterol diet with angiotensin II (n=60) or normal saline (n=12) by implanting osmotic mini-pumps and evaluated AAA formation at 16 weeks. The angiotensin II-infused mice received interleukin-2/anti-interleukin-2 monoclonal antibody complex (interleukin-2 complex; n=31) or PBS (n=29). Eighty-one percent of angiotensin II-infused mice developed AAA, with 42% mortality possibly because of aneurysm rupture. Interleukin-2 complex treatment systemically increased the number of Foxp3(+) Tregs and significantly decreased the incidence (52%) and mortality (17%) of AAA. Immunohistochemical analysis showed reduced accumulation of macrophages and increased numbers of Foxp3(+) Tregs in aneurysmal tissues, suggesting that expansion of Tregs may suppress local inflammation in the vessel wall and provide protection against AAA formation. Furthermore, genetic depletion of Foxp3(+) Tregs led to a significant increase in the mortality of AAA, suggesting the protective role of Foxp3(+) Tregs against AAA. Our findings suggest that Foxp3(+) Tregs may play a protective role in AAA formation and that promotion of an endogenous regulatory immune response may be a potentially valuable therapeutic approach for preventing AAA.Entities:
Keywords: T-lymphocytes, regulatory; aortic aneurysm, abdominal; immunology; inflammation; interleukin-2
Mesh:
Substances:
Year: 2015 PMID: 25601931 DOI: 10.1161/HYPERTENSIONAHA.114.04934
Source DB: PubMed Journal: Hypertension ISSN: 0194-911X Impact factor: 10.190